Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jillian G Baker

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 7, 2011
The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptorJillian G Baker, Richard G W Proudman, Christopher G Tate
Plos One|November 20, 2013
Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptorJillian G Baker, Richard G W Proudman, Stephen J Hill
Molecular Pharmacology|October 18, 2014
Salmeterol's extreme β2 selectivity is due to residues in both extracellular loops and transmembrane domainsJillian G Baker, Richard G W Proudman, Stephen J Hill
Journal of Medicinal Chemistry|September 26, 2020
Structure-Based Discovery of Novel Ligands for the Orexin 2 ReceptorJakub Gunera, Jillian G Baker, Niek van Hilten, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 4, 2015
Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformationKarolina Gherbi, Lauren T May, Jillian G Baker, et al.
European Journal of Medicinal Chemistry|December 10, 2022
Rational design, synthesis, and pharmacological evaluation of a cohort of novel beta-adrenergic receptors ligands enables an assessment of structure-activity relationshipsJacopo Tricomi, Luca Landini, Valentina Nieddu, et al.
Molecular Pharmacology|November 9, 2022
The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human <i>β</i>1-AdrenoceptorVictor Jun Yu Lim, Richard G W Proudman, Stefania Monteleone, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 2011
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responsesJillian G Baker, Philip Kemp, Julie March, et al.
Molecular Pharmacology|August 9, 2008
Role of key transmembrane residues in agonist and antagonist actions at the two conformations of the human beta1-adrenoceptorJillian G Baker, Richard G W Proudman, Nicola C Hawley, et al.
Molecular Pharmacology|November 25, 2025
Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptorJillian G Baker, Victor Jun Yu Lim, Richard G W Proudman, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 7, 2011
The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptorJillian G Baker, Richard G W Proudman, Christopher G Tate
Plos One|November 20, 2013
Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptorJillian G Baker, Richard G W Proudman, Stephen J Hill
Molecular Pharmacology|October 18, 2014
Salmeterol's extreme β2 selectivity is due to residues in both extracellular loops and transmembrane domainsJillian G Baker, Richard G W Proudman, Stephen J Hill
Journal of Medicinal Chemistry|September 26, 2020
Structure-Based Discovery of Novel Ligands for the Orexin 2 ReceptorJakub Gunera, Jillian G Baker, Niek van Hilten, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 4, 2015
Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformationKarolina Gherbi, Lauren T May, Jillian G Baker, et al.
European Journal of Medicinal Chemistry|December 10, 2022
Rational design, synthesis, and pharmacological evaluation of a cohort of novel beta-adrenergic receptors ligands enables an assessment of structure-activity relationshipsJacopo Tricomi, Luca Landini, Valentina Nieddu, et al.
Molecular Pharmacology|November 9, 2022
The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human <i>β</i>1-AdrenoceptorVictor Jun Yu Lim, Richard G W Proudman, Stefania Monteleone, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 2011
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responsesJillian G Baker, Philip Kemp, Julie March, et al.
Molecular Pharmacology|August 9, 2008
Role of key transmembrane residues in agonist and antagonist actions at the two conformations of the human beta1-adrenoceptorJillian G Baker, Richard G W Proudman, Nicola C Hawley, et al.
Molecular Pharmacology|November 25, 2025
Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptorJillian G Baker, Victor Jun Yu Lim, Richard G W Proudman, et al.
Pageof 6